hendra
viru
hev
emerg
two
separ
outbreak
sever
respiratori
diseas
hors
subsequ
transmiss
human
result
close
contact
infect
hors
nipah
viru
niv
later
determin
caus
agent
major
outbreak
diseas
pig
along
case
febril
enceph
among
peopl
malaysia
singapor
close
contact
exposur
infect
pig
review
phylogenet
analysi
reveal
hev
niv
distinct
member
paramyxovirida
prototyp
member
new
genu
henipaviru
within
paramyxoviru
famili
pteropid
fruit
bat
commonli
known
fli
fox
famili
pteropodida
princip
natur
reservoir
niv
hev
review
howev
recent
evid
henipaviru
infect
wider
rang
frugivor
insectivor
bat
report
sinc
identif
hev
niv
caus
repeat
spillov
event
recogn
occurr
hev
australia
sinc
least
one
occurr
per
year
sinc
recent
may
everi
outbreak
hev
involv
hors
initi
infect
host
caus
lethal
respiratori
diseas
enceph
along
total
seven
human
case
aris
exposur
infect
hors
among
four
fatal
recent
review
comparison
dozen
occurr
niv
emerg
sinc
initi
recognit
appear
bangladesh
india
review
recent
march
januari
among
spillov
event
niv
human
mortal
rate
higher
along
evid
persontoperson
transmiss
direct
transmiss
viru
fli
fox
human
via
contamin
food
contrast
paramyxovirus
niv
hev
exhibit
extrem
broad
host
tropism
addit
bat
hors
pig
human
natur
andor
experiment
infect
also
report
cat
dog
guinea
pig
hamster
review
ferret
nonhuman
primat
squirrel
monkey
african
green
monkey
host
suscept
henipavirusinduc
patholog
diseas
character
widespread
multisystem
vascul
viru
replic
associ
patholog
highli
vascular
tissu
includ
lung
spleen
brain
broad
host
tissu
tropism
exhibit
niv
hev
part
explain
highli
conserv
broadli
express
natur
receptor
henipavirus
employ
ligand
member
larg
famili
import
signal
protein
involv
cellcel
interact
review
niv
hev
possess
two
envelop
glycoprotein
anchor
within
viral
membran
trimer
fusion
f
tetramer
attach
g
glycoprotein
review
f
glycoprotein
initi
synthes
precursor
cleav
disulfidelink
subunit
cathepsin
l
within
host
cell
g
glycoprotein
consist
stalk
domain
globular
head
g
monom
form
disulfidelink
dimer
associ
pair
form
tetram
f
g
oligom
associ
within
membran
g
respons
engag
receptor
turn
trigger
fmediat
membran
fusion
review
f
g
glycoprotein
niv
hev
share
amino
acid
ident
niv
hev
elicit
crossreact
antienvelop
glycoprotein
antibodi
respons
also
demonstr
f
g
niv
hev
effici
complement
heterotyp
manner
cellfus
assay
henipaviru
f
g
glycoprotein
share
mani
gener
structur
featur
found
envelop
glycoprotein
paramyxovirus
recent
structur
receptorbound
unbound
form
globular
head
domain
niv
g
report
highli
pathogen
natur
lack
approv
vaccin
therapeut
hev
niv
classifi
biolog
safeti
select
agent
center
diseas
control
prevent
cdc
prioriti
pathogen
nation
institut
allergi
infecti
diseas
niaid
potenti
caus
signific
morbid
mortal
human
major
econom
public
health
impact
review
restrict
somewhat
limit
detail
studi
viru
entri
envelop
glycoprotein
function
context
viral
particl
circumv
restrict
viru
pseudotyp
system
examin
envelop
glycoprotein
one
viru
incorpor
progeni
virion
anoth
lack
envelop
glycoprotein
effect
chang
host
rang
tropism
viru
exampl
f
g
envelop
glycoprotein
niv
success
incorpor
recombin
vesicular
stomat
viru
vsv
lack
vsv
g
glycoprotein
encod
green
fluoresc
protein
gfp
wide
employ
viral
pseudotyp
system
base
retrovir
vector
lentivir
vector
emerg
promis
tool
varieti
genedeliveri
studi
effici
transduc
prolifer
well
quiescent
cell
review
viru
pseudotyp
system
use
studi
otherwis
highli
pathogen
viral
agent
ebola
marburg
virus
sever
acut
respiratori
syndrom
sar
coronaviru
sarscov
influenza
viru
build
initi
find
kobayashi
et
al
first
demonstr
simian
immunodefici
viru
african
green
monkey
sivagm
could
function
pseudotyp
f
hemagglutininneuraminidas
hn
glycoprotein
sendai
viru
sev
demonstr
first
time
f
g
envelop
glycoprotein
niv
hev
cellular
protein
receptor
use
paramyxoviru
also
function
pseudotyp
lentiviru
particl
use
either
luciferas
gfp
report
gene
encod
genom
base
henipaviru
glycoprotein
pseudotyp
particl
exhibit
cellular
tropism
characterist
authent
niv
hev
viru
entri
specif
inhibit
antivir
agent
target
henipavirus
pseudotyp
particl
could
readili
concentr
ultracentrifug
without
loss
infect
use
system
also
examin
incorpor
f
g
glycoprotein
virion
explor
infect
pseudotyp
effici
cytoplasm
tail
truncat
version
f
lentivirusbas
henipaviru
glycoprotein
pseudotyp
particl
infect
assay
also
conduct
safe
condit
use
tool
measur
henipaviru
entri
studi
f
g
glycoprotein
function
context
viru
particl
entri
well
assay
character
neutral
antibodi
viru
entri
inhibitor
often
desir
studi
function
viral
envelop
glycoprotein
involv
attach
membran
fusion
entri
context
viral
particl
exampl
infect
experi
use
viru
particl
confirm
observ
made
cellcel
fusion
assay
studi
viru
tropism
character
antivir
agent
target
variou
stage
viru
entri
process
howev
work
infecti
henipavirus
restrict
contain
rais
cost
safeti
issu
counter
limit
sought
develop
henipaviru
envelop
glycoprotein
pseudotyp
system
use
report
geneencod
lentiviru
vector
would
provid
viru
entri
assay
base
function
f
g
glycoprotein
could
safe
routin
carri
condit
test
possibl
pseudotyp
retroviru
particl
produc
transfect
use
plasmid
contain
provir
clone
encod
luciferas
produc
envelop
glycoprotein
along
pcagg
express
vector
encod
niv
hev
f
g
glycoprotein
prepar
henipaviru
glycoprotein
pseudotyp
viru
particl
control
viru
particl
lack
glycoprotein
normal
content
elisa
see
method
use
infect
sever
human
cell
line
tk
long
known
permiss
henipavirusmedi
cellcel
fusion
henipaviru
receptor
neg
fusion
infect
resist
cell
line
helausu
pseudotyp
viru
particl
gener
niv
f
g
glycoprotein
abl
infect
produc
luciferas
report
gene
activ
variou
level
permiss
receptor
express
cell
figur
signal
observ
receptor
neg
helausu
control
viru
particl
gener
transfect
empti
vector
pcagg
surprisingli
howev
viru
particl
produc
use
pcagg
express
plasmid
encod
hev
f
g
glycoprotein
consist
nonfunct
measur
luciferas
activ
data
shown
express
vector
pcagg
mammalian
express
vector
cytomegaloviru
cmv
immedi
earli
enhanc
link
chicken
promot
cag
promot
intron
splice
acceptor
site
rabbit
gene
result
splice
premrna
increas
stabil
express
mrna
enhanc
product
encod
protein
although
featur
make
pcagg
effici
vector
express
gene
nucleu
found
problemat
express
hev
g
glycoprotein
rna
viru
gene
normal
express
cytoplasm
infect
cell
express
level
hev
g
significantli
lower
comparison
niv
g
system
data
shown
analysi
hev
g
gene
clone
pcagg
use
splice
site
predict
softwar
emblebi
http
wwwebiacukasdsrvwbcgi
reveal
possibl
splice
site
within
hev
g
code
region
figur
none
present
niv
g
glycoprotein
pcagg
construct
addit
file
fig
mutat
introduc
sitedirect
mutagenesi
remov
predict
splice
site
singli
differ
combin
keep
amino
acid
code
sequenc
unalt
panel
seven
hev
g
mutant
clone
gener
figur
hev
g
splice
mutant
construct
test
express
plasmid
transfect
indic
remov
predict
splice
site
improv
hev
g
glycoprotein
product
remov
three
site
optim
mrna
express
altern
splice
pattern
confirm
northern
blot
analysi
result
shown
seri
pseudotyp
viru
particl
prepar
use
hev
f
along
hev
g
splice
mutant
addit
control
viru
particl
also
prepar
use
hev
f
along
empti
vector
pcagg
wildtyp
hev
g
wildtyp
niv
g
seri
pseudotyp
viru
particl
use
infect
target
cell
shown
figur
hev
g
splice
mutant
put
splice
site
remov
combin
hev
f
abl
produc
function
pseudotyp
particl
measur
luciferas
report
gene
activ
signal
level
compar
niv
f
g
bear
particl
figur
remaind
hev
g
splice
mutant
show
low
level
report
gene
signal
wherea
wildtyp
hev
g
result
demonstr
splice
site
remov
mutat
hev
restor
abil
hev
g
express
context
pcagg
thu
allow
incorpor
lentiviru
particl
addit
function
particl
also
gener
use
hev
f
heterotyp
combin
niv
g
confirm
previou
heterotyp
cellcel
fusion
activ
observ
henipavirus
heterotyp
pseudotyp
particl
yield
report
gene
activ
essenti
equival
hev
hev
f
particl
figur
similar
signal
obtain
niv
f
g
bear
particl
figur
confirm
find
demonstr
expand
util
henipaviru
envelop
glycoprotein
pseudotyp
system
niv
hev
f
g
glycoprotein
bear
lentiviru
particl
prepar
gfp
report
gene
encod
construct
use
infect
receptor
posit
cell
figur
product
infect
cell
visual
use
fluoresc
microscop
hr
postinfect
fluoresc
cell
observ
cell
infect
pseudotyp
virion
prepar
either
niv
f
niv
g
hev
f
hev
gfp
express
cell
observ
well
infect
virion
prepar
empti
vector
pcagg
viru
particl
prepar
hev
f
wildtyp
hev
g
examin
cellular
infect
specif
hev
niv
f
g
pseudotyp
particl
sever
henipaviru
specif
reagent
capabl
block
viru
infect
test
abil
inhibit
infect
henipaviru
pseudotyp
viru
particl
prepar
mix
variou
inhibitor
figur
henipaviru
specif
peptid
fusion
inhibitor
amino
acid
peptid
correspond
henipaviru
heptad
repeat
region
f
glycoprotein
complet
block
entri
henipaviru
pseudotyp
measur
luciferas
report
gene
activ
peptid
function
analog
manner
specif
fusion
inhibitor
enfuvirtid
formerli
specif
block
format
class
fusion
glycoprotein
structur
known
bundl
f
glycoprotein
prevent
fmediat
membran
fusion
subsequ
virion
entri
scrambl
version
peptid
sc
use
neg
control
infect
specif
also
examin
inhibit
crossreact
antihenipaviru
g
glycoprotein
human
monoclon
antibodi
mab
mab
neutral
henipavirus
specif
bind
block
receptorbind
region
henipaviru
g
glycoprotein
shown
figur
infect
either
hev
niv
pseudotyp
complet
block
mab
confirm
entri
result
luciferas
signal
specif
mediat
attach
subsequ
fusion
trigger
function
henipaviru
g
glycoprotein
addit
bind
infect
henipaviru
pseudotyp
target
cell
could
block
recombin
solubl
receptor
figur
hev
niv
f
g
bear
particl
preincub
solubl
unabl
infect
host
cell
previous
shown
infecti
viru
also
reciproc
manner
recombin
solubl
niv
g
sg
could
block
entri
either
henipaviru
pseudotyp
similar
earlier
observ
made
hev
sg
infecti
viru
entri
togeth
result
demonstr
specif
henipaviru
f
g
glycoprotein
bear
pseudotyp
viru
entri
assay
potenti
util
screen
specif
henipaviru
entri
inhibitor
previou
studi
demonstr
effici
incorpor
heterolog
envelop
glycoprotein
murin
leukemia
viru
mlv
particl
often
depend
remov
part
cytoplasm
tail
domain
pseudotyp
glycoprotein
explor
whether
similar
featur
occur
henipaviru
pseudotyp
system
seri
seven
cytoplasm
tail
truncat
mutat
henipaviru
f
glycoprotein
gener
design
introduc
translat
stop
codon
code
sequenc
niv
hev
f
gene
figur
construct
niv
hev
f
differ
one
addit
delet
valin
residu
better
ensur
complet
remov
cytoplasm
tail
domain
cytoplasm
tail
truncat
membran
anchor
protein
could
affect
proper
fold
transport
first
examin
level
cell
surfac
express
f
compar
seri
truncat
mutant
f
construct
wildtyp
f
use
cell
surfac
biotinyl
assay
seri
niv
hev
f
glycoprotein
mutant
wildtyp
f
express
plasmid
transfect
helausu
cell
presenc
absenc
homolog
g
glycoprotein
partner
surfac
protein
biotin
label
precipit
avidinagaros
analyz
western
blot
assay
use
specif
antisera
figur
wildtyp
niv
precursor
cleav
detect
appear
less
effici
cleav
level
versu
compar
wildtyp
niv
f
signific
amount
niv
construct
cleav
appear
highli
process
although
overal
express
lower
comparison
other
ratio
cleav
uncleav
f
cell
surfac
approxim
equal
complet
retent
endocytosi
motif
ysrl
retain
begin
construct
notabl
coexpress
niv
g
appear
significantli
alter
express
cleavag
pattern
niv
f
figur
retent
amino
acid
residu
endocytosi
motif
ysrl
residu
edrrv
cytoplasm
tail
appear
allow
effici
process
evidenc
greater
level
observ
niv
construct
niv
figur
comparison
niv
lack
ysrl
motif
addit
cell
surfac
level
f
primarili
observ
construct
appear
greater
comparison
construct
mostli
like
reflect
reduc
abil
precursor
endocytos
process
cathepsin
l
similar
result
obtain
seri
hev
f
cytoplasm
tail
truncat
mutant
examin
parallel
hev
f
construct
reveal
greater
cell
surfac
express
level
less
effici
process
measur
detect
wherea
hev
f
construct
reveal
greater
precursor
process
perhap
overal
lower
level
express
figur
variabl
doublet
appear
hev
observ
previous
niv
f
truncat
mutant
coexpress
hev
f
panel
along
hev
g
glycoprotein
partner
significantli
alter
hev
f
express
cleavag
pattern
observ
cell
surfac
biotinyl
assay
character
express
process
cytoplasm
tail
truncat
mutant
niv
hev
f
glycoprotein
next
examin
biolog
function
cellcel
membran
fusion
assay
membran
fusion
assess
use
wellcharacter
vaccinia
virusbas
reportergen
cellcel
fusion
assay
assay
also
use
extens
earlier
report
character
hev
nivmedi
membran
fusion
tropism
seri
f
glycoprotein
truncat
mutant
hev
niv
express
along
respect
partner
g
glycoprotein
helausu
cell
effector
cell
cellcel
fusion
reaction
carri
use
target
cell
either
receptor
neg
helausu
control
fusion
permiss
cell
result
shown
figur
niv
f
remov
cytoplasm
tail
domain
f
also
reduc
process
impair
fusogen
potenti
would
expect
wherea
fusogen
activ
niv
either
equival
slightli
elev
comparison
wildtyp
niv
f
cellcel
fusion
assay
seri
hev
f
truncat
mutant
gener
slightli
variabl
result
contrast
niv
f
though
possess
fusogen
activ
gener
slight
reduct
fusion
hev
f
essenti
equival
wildtyp
hev
f
lower
fusion
signal
seen
hev
could
relat
overal
lower
express
level
seen
figur
comparison
result
figur
figur
suggest
niv
f
process
appear
correl
cellcel
fusion
signal
wherea
cellcel
fusion
activ
readili
appar
sever
hev
f
truncat
mutant
possess
markedli
lower
level
process
howev
independ
experi
direct
comparison
may
misslead
next
examin
effici
variou
cytoplasm
tail
truncat
mutant
niv
hev
f
glycoprotein
incorpor
lentivirusbas
pseudotyp
pseudotyp
lentiviru
particl
prepar
use
seri
cytoplasm
tail
truncat
mutant
along
partner
g
glycoprotein
three
type
control
viru
particl
also
prepar
use
either
empti
vector
pcagg
speci
wildtyp
f
glycoprotein
alon
speci
g
glycoprotein
alon
pseudotyp
viru
particl
prepar
filter
purifi
centrifug
sucros
cushion
normal
content
elisa
use
infect
target
cell
follow
infect
incub
h
cell
process
luciferas
activ
measur
shown
figur
pseudoviru
particl
prepar
use
truncat
mutant
f
glycoprotein
produc
significantli
greater
level
luciferas
activ
compar
viru
particl
made
wildtyp
f
evalu
whether
differ
infect
measur
luciferas
report
gene
activ
variou
pseudoviru
type
correl
extent
incorpor
mutant
f
glycoprotein
lentiviru
particl
equal
amount
viru
particl
base
content
lyse
analyz
western
blot
analysi
reveal
incorpor
f
either
niv
hev
pseudotyp
virion
greater
construct
predomin
speci
present
virion
figur
result
togeth
cell
surfac
express
pattern
niv
hev
wildtyp
truncat
mutant
demonstr
gener
amount
incorpor
f
glycoprotein
pseudotyp
particl
appear
correl
well
level
express
protein
surfac
produc
cell
also
true
amount
wildtyp
niv
hev
f
alon
bear
particl
note
compar
figur
figur
remov
endocytosi
motif
fusion
protein
prevent
transport
endosom
subsequ
cleavag
cathepsin
l
explain
predomin
construct
lack
endocytosi
motif
ysrl
interestingli
niv
hev
f
glycoprotein
mutant
seri
higher
infect
bear
pseudotyp
comparison
wildtyp
notabl
might
attribut
greater
level
incorpor
f
glycoprotein
particl
except
case
wildtyp
niv
f
g
bear
particl
reason
later
observ
unclear
present
altern
howev
also
interest
high
infect
signal
predomin
pseudotyp
prepar
could
argu
role
endocytosi
follow
cathepsin
l
process
subsequ
product
fusion
infect
present
studi
detail
new
readili
adapt
reportergen
contain
lentivirusbas
pseudotyp
system
util
function
f
g
envelop
glycoprotein
henipavirus
niv
hev
importantli
like
viru
envelop
glycoprotein
pseudotyp
system
assay
conduct
safe
condit
relev
consid
otherwis
highli
pathogen
natur
infecti
niv
hev
also
demonstr
sever
measur
henipaviru
pseudotyp
system
faith
recapitul
natur
niv
hev
cell
attach
viral
glycoproteinmedi
membran
fusion
stage
infect
henipavirus
bind
infect
host
cell
specif
attach
step
cell
surfac
express
protein
current
wide
accept
model
paramyxoviru
mediat
membran
fusion
postul
upon
receptor
bind
viral
attach
glycoprotein
trigger
conform
chang
f
glycoprotein
class
viral
fusion
glycoprotein
receptorinduc
trigger
event
presum
involv
direct
contact
attach
fusion
glycoprotein
activ
process
facilit
seri
conform
chang
f
glycoprotein
transit
postfus
sixhelixbundl
conform
concomit
merg
viral
membran
envelop
host
cell
plasma
membran
howev
detail
entir
receptor
bind
fusion
activ
process
yet
defin
import
featur
mani
class
fusion
glycoprotein
two
region
refer
heptad
repeat
hr
domain
involv
format
sixhelixbundl
structur
locat
proxim
amino
n
termin
fusion
peptid
preced
transmembran
domain
near
carboxyl
c
terminu
peptid
sequenc
either
hr
domain
f
glycoprotein
sever
paramyxovirus
includ
hev
niv
shown
inhibitor
fmediat
membran
fusion
step
cellcel
fusion
viru
infect
assay
shown
infecti
viru
cellcel
fusion
assay
infect
niv
hev
f
g
lentiviru
pseudotyp
complet
block
base
fusion
inhibit
peptid
number
test
also
conduct
demonstr
specif
henipaviru
pseudotyp
system
addit
use
henipaviru
peptid
fusion
inhibitor
competit
assay
infect
pseudotyp
could
also
specif
block
use
recombin
solubl
receptor
protein
previous
shown
henipavirusmedi
membran
fusion
well
live
viru
infect
assay
similar
fashion
recombin
solubl
henipaviru
g
glycoprotein
sg
also
abl
complet
inhibit
infect
either
hev
niv
pseudotyp
block
receptor
bind
demonstr
previous
henipavirusmedi
membran
fusion
live
viru
infect
assay
final
infect
niv
hev
pseudotyp
could
also
complet
block
use
wellcharacter
crossreact
human
mab
specif
henipaviru
g
glycoprotein
thu
wide
varieti
wellknown
wellcharacter
approach
function
henipaviru
envelop
glycoprotein
pseudotyp
lentiviru
assay
system
develop
accur
recapitul
receptor
bind
membran
fusion
infect
stage
live
hev
niv
highli
pathogen
featur
niv
hev
restrict
use
infecti
viru
contain
labor
intens
natur
challeng
associ
revers
genet
approach
extens
detail
structur
function
studi
henipaviru
envelop
glycoprotein
context
viral
particl
limit
demonstr
util
henipaviru
pseudotyp
system
gener
test
extens
panel
cytoplasm
tail
domain
truncat
mutant
niv
hev
f
glycoprotein
examin
influenc
domain
f
abil
incorpor
bud
particl
well
fusion
activ
context
viral
particl
observ
delet
essenti
entir
f
cytoplasm
tail
domain
notabl
niv
f
glycoprotein
lesser
degre
hev
f
impair
fusogen
activ
context
cellcel
fusion
assay
find
contrast
previou
observ
made
envelop
glycoprotein
certain
lentivirus
studi
human
immunodefici
viru
type
simian
immunodefici
viru
siv
envelop
env
glycoprotein
shown
cytoplasm
domain
truncat
mutant
exhibit
significantli
enhanc
env
fusogen
activ
measur
syncytium
format
addit
studi
murin
leukemia
viru
demonstr
natur
occur
late
cleavag
small
carboxi
termin
sequenc
design
r
peptid
cytoplasm
tail
result
consider
enhanc
celltocel
fusion
activ
wherea
paramyxoviru
f
glycoprotein
cytoplasm
tail
delet
simian
viru
newcastl
diseas
viru
human
parainfluenza
viru
hpiv
type
reveal
significantli
reduc
syncytium
format
except
one
exampl
similar
delet
affect
membran
fusion
overal
except
result
studi
also
demonstr
subsequ
addit
part
delet
cytoplasm
tail
sequenc
restor
fusogen
potenti
f
glycoprotein
case
henipavirus
one
explan
account
reduc
fusion
activ
entir
cytoplasm
tail
delet
construct
poor
endocytosi
subsequ
cathepsin
l
process
analysi
surfac
express
level
niv
versu
cytoplasm
tail
domain
truncat
mutant
support
conclus
lesser
extent
hev
f
truncat
mutant
howev
although
cellcel
fusogen
result
truncat
construct
henipaviru
f
glycoprotein
report
similar
major
observ
made
paramyxovirus
whether
result
precursor
process
mechan
cytoplasm
tail
delet
hev
niv
f
glycoprotein
context
viru
particl
pseudotyp
system
reveal
oppos
result
gener
higher
level
pseudotyp
particl
infect
signal
correl
overal
greater
level
incorpor
f
glycoprotein
interestingli
howev
highest
luciferas
signal
viru
infect
assay
also
correl
greater
level
unprocess
particl
particularli
cytoplasm
tail
delet
potenti
greater
luciferas
signal
instanc
could
due
particl
endocytosi
follow
receptor
bind
subsequ
process
cathepsin
l
pseudotyp
system
describ
offer
one
system
albeit
artifici
explor
possibl
product
earli
endocyt
rout
henipaviru
infect
taken
togeth
henipaviru
pseudotyp
system
shown
offer
use
tool
measur
henipaviru
entri
assay
character
viru
neutral
antibodi
viru
entri
inhibitor
also
offer
highli
versatil
platform
studi
f
g
glycoprotein
function
context
viru
particl
infect
one
readili
assay
numer
variat
mutant
either
f
g
henipaviru
glycoprotein
function
henipaviru
envelop
glycoprotein
pseudotyp
report
gene
encod
lentiviru
particl
could
readili
produc
concentr
ultracentrifug
store
frozen
without
loss
infect
henipaviru
pseudotyp
particl
maintain
cellular
tropism
characterist
authent
niv
hev
infect
host
cell
particl
could
specif
inhibit
variou
antivir
agent
target
henipavirus
henipaviru
glycoprotein
pseudotyp
viru
infect
assay
conduct
safe
condit
util
analyz
viral
glycoprotein
function
otherwis
restrict
agent
context
viru
particl
demonstr
character
cytoplasm
tail
truncat
version
f
glycoprotein
new
henipaviru
pseudotyp
system
use
tool
measur
hev
niv
entri
studi
f
g
glycoprotein
function
context
viru
particl
well
assay
character
neutral
antibodi
viru
entri
inhibitor
obtain
american
type
cultur
collect
atcc
recombin
human
osteosarcoma
cell
bear
obtain
nih
aid
research
refer
reagent
program
cell
obtain
dr
g
quinnan
uniform
servic
univers
helausu
cell
line
describ
previous
helausu
cell
maintain
dulbecco
modifi
eagl
medium
qualiti
biolog
gaithersburg
md
supplement
cosmic
calf
serum
cc
hyclon
logan
ut
mm
lglutamin
cell
cultur
maintain
humidifi
atmospher
hev
niv
f
g
envelop
glycoprotein
transient
express
use
mammalian
express
vector
pcagg
contain
cag
promot
compos
cytomegaloviru
immedi
earli
enhanc
chicken
promot
backbon
plasmid
encod
luciferas
luc
green
fluoresc
protein
gfp
report
gene
provid
dr
r
dom
univers
pennsylvania
henipaviru
g
f
glycoprotein
detect
crossreact
polyclon
mous
antiserum
rais
recombin
solubl
hev
g
rabbit
polyclon
henipaviru
antiserum
provid
dr
lf
wang
australian
anim
health
laboratori
geelong
australia
respect
human
monoclon
antibodi
mab
igg
use
inhibit
viru
entri
provid
dr
dimitrov
nation
cancer
institutefrederick
nation
institut
health
fusion
inhibit
peptid
correspond
region
niv
f
nonfus
inhibit
scrambl
control
peptid
previous
describ
recombin
solubl
r
system
minneapoli
mn
recombin
solubl
niv
g
niv
sg
previous
describ
fulllength
cdna
clone
niv
hev
f
glycoprotein
gene
includ
kozak
consensu
sequenc
ccacc
append
upstream
initi
atg
subclon
pcagg
gener
niv
fpcagg
hev
fpcagg
express
vector
cytoplasm
tail
domain
truncat
mutant
niv
hev
f
gener
introduc
stop
codon
correspond
amino
acid
posit
fulllength
f
glycoprotein
standard
pcr
techniqu
niv
fpcagg
hev
fpcagg
plasmid
use
templat
primer
includ
extern
ecori
site
kozak
consensu
sequenc
ccacc
fspecif
sequenc
variou
primer
includ
f
specif
sequenc
stop
codon
desir
locat
extern
kpni
site
pcr
product
gel
purifi
clone
topo
vector
invitrogen
subsequ
subclon
pcagg
gener
construct
niv
hev
figur
construct
sequenc
confirm
fulllength
cdna
clone
niv
hev
g
glycoprotein
gene
includ
kozak
consensu
sequenc
ccacc
append
upstream
initi
atg
subclon
pcagg
gener
niv
gpcagg
hev
gpcagg
express
vector
splice
site
mutat
figur
hev
g
gene
gener
sitedirect
mutagenesi
use
quickchang
ii
sitedirect
mutagenesi
kit
quickchang
multi
sitedirect
mutagenesi
kit
stratagen
cedar
creek
tx
templat
mutagenesi
reaction
hev
g
clone
topo
plasmid
invitrogen
corp
carlsbad
ca
first
donor
splice
site
nucleotid
posit
ttg
codon
leucin
chang
ctt
redund
codon
leucin
ctg
cta
ctc
tta
effect
remov
predict
splice
site
second
donor
splice
site
nucleotid
posit
agt
codon
serin
chang
tcg
third
donor
splice
site
nucleotid
posit
ggg
codon
glycin
chang
ggt
pcr
product
gel
purifi
clone
topo
subsequ
subclon
pcagg
mutationcontain
construct
sequenc
verifi
helausu
cell
grown
flask
transfect
pcagg
express
construct
niv
hev
f
alon
along
partner
g
glycoprotein
construct
fugen
reagent
roch
diagnost
corp
hr
follow
express
cell
rins
three
time
icecold
phosphat
buffer
salin
pb
cell
surfac
protein
biotinyl
use
mgml
ezlink
nhsbiotin
pierc
rockford
il
pb
min
reaction
quench
wash
cell
monolay
three
time
icecold
pb
harvest
cell
prepar
cell
lysat
cell
lyse
mm
trishcl
ph
mm
nacl
triton
proteas
inhibitor
min
onehalf
lysat
incub
volvol
solut
agaroseavidin
bead
vector
laboratori
inc
burlingam
ca
ip
buffer
nacl
tri
triton
rotat
overnight
bead
wash
twice
lysi
buffer
follow
one
wash
doc
buffer
mm
trishcl
ph
mm
nacl
sodium
deoxychol
sd
sampl
boil
sdspage
sampl
buffer
separ
trisglycin
gradient
gel
invitrogen
transfer
nitrocellulos
probe
crossreact
polyclon
mous
antiserum
hev
g
concentr
rabbit
polyclon
specif
antiserum
concentr
henipaviru
f
g
mediat
fusion
activ
measur
use
previous
describ
quantit
viral
glycoproteinmedi
cellcel
fusion
assay
briefli
one
cell
popul
effector
cell
infect
recombin
vaccinia
viru
express
polymeras
cell
popul
target
cell
infect
vaccinia
viru
encod
e
coli
lacz
gene
gene
control
promot
cellcel
fusion
effector
target
cell
result
synthesi
measur
specif
synthet
substrat
cleavag
plasmid
encod
niv
hev
g
along
respect
wildtyp
f
glycoprotein
partner
variou
truncat
mutant
f
transfect
helausu
cell
allow
express
overnight
effector
cell
popul
effector
cell
popul
also
prepar
use
empti
vector
pcagg
niv
hev
f
glycoprotein
alon
addit
neg
control
variou
effector
cell
popul
infect
fusion
permiss
target
cell
popul
prepar
infect
vaccinia
viru
infect
carri
multipl
infect
suspend
media
incub
overnight
previous
describ
cell
fusion
reaction
conduct
variou
cell
mixtur
plate
ratio
envelop
glycoproteinexpress
cell
target
cell
use
total
cell
per
well
total
volum
ml
per
well
h
quantit
analys
nonidet
ad
volvol
aliquot
cellcel
fusion
lysat
assay
ambient
temperatur
substrat
chlorophenol
reddgalactopyranosid
roch
diagnost
corp
usa
assay
perform
triplic
fusion
result
calcul
express
rate
activ
chang
optic
densiti
nm
per
minut
mrx
micropl
reader
dynatech
laboratori
chantilli
va
pseudotyp
report
gene
encod
viru
stock
prepar
transfect
cell
report
geneencod
backbon
plasmid
along
henipaviru
envelop
glycoprotein
encod
pcagg
vector
cell
seed
flatbottom
collagen
icoat
micropl
bd
bioscienc
durham
nc
transfect
express
plasmid
use
fugen
reagent
roch
diagnost
corp
dna
along
hev
niv
f
g
encod
pcagg
plasmid
mix
ratio
respect
ad
serum
free
dmem
fugen
mixtur
incub
room
temperatur
min
appli
cultur
cell
hr
incub
transfect
cell
wash
extens
dmem
incub
addit
hr
ml
supernat
viru
particl
produc
cultur
collect
clarifi
centrifug
min
rpm
filter
low
protein
bind
syring
filter
millipor
bedford
partial
purifi
wtvol
sucros
hepesnacl
buffer
centrifug
g
hr
pellet
resuspend
overnight
sucros
hepesnacl
buffer
use
immedi
store
measur
incorpor
henipaviru
f
g
glycoprotein
pseudotyp
particl
sucros
cushion
purifi
particl
lyse
buffer
contain
mm
trishcl
ph
mm
nacl
triton
proteas
inhibitor
min
sampl
boil
sdspage
sampl
buffer
separ
trisglycin
gradient
gel
invitrogen
transfer
nitrocellulos
probe
crossreact
polyclon
mous
antiserum
hev
g
concentr
rabbit
polyclon
specif
antiserum
concentr
receptor
posit
cell
line
seed
plate
concentr
cell
per
well
infect
transduc
pseudoviru
normal
antigen
content
use
eia
kit
beckmancoult
infect
experi
carri
triplic
well
deaedextran
polybren
use
facilit
fusioninfect
pseudovirion
infect
hr
cell
wash
incub
addit
hr
luciferas
encod
particl
cell
lyse
triton
pb
aliquot
lysat
assay
luciferas
activ
use
luciferas
substrat
promega
madison
wi
mikrowin
luminomet
berthold
technolog
model
centro
lb
gfpencod
particl
effici
infect
evalu
count
number
green
cell
h
postinfect
use
olympu
fluoresc
microscop
inhibit
pseudotyp
viru
infect
assay
base
viru
particl
pseudotyp
fulllength
niv
hev
f
g
envelop
glycoprotein
preincub
nivsg
igg
fusion
inhibit
scrambl
control
peptid
recombin
solubl
murin
recombin
solubl
human
hr
receptor
posit
cell
seed
plate
cell
per
well
infect
variou
pretreat
pseudotyp
viru
particl
process
infect
experi
perform
triplic
author
declar
compet
interest
dk
contribut
develop
henipaviru
pseudoviru
assay
design
construct
express
construct
carri
experi
identifi
altern
splice
process
origin
hendra
viru
g
encod
pcagg
plasmid
clone
interpret
data
wrote
first
draft
figur
manuscript
ccb
conceiv
contribut
develop
henipaviru
pseudoviru
assay
provid
overal
supervis
financi
support
wrote
prepar
final
version
figur
manuscript
author
read
approv
final
manuscript
